Axcelis Technologies, Inc.
ACLSTechnologyNASDAQSemiconductor Equipment & Materials
Scan Results
Daily timeframeAxcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. With a market capitalization of $4.19B, it sits in mid-cap territory. The company provides high energy, high current, and medium current implanters for various application requirements.
Market Cap
$4.19B
Beta
1.87
P/E (TTM)
43.31
P/E (Fwd)
28.14
EPS (TTM)
$3.15
EPS (Fwd)
$4.85
ROE
9.7%
ROA
4.5%
Cash
$366.6M
Total Debt
$70.5M
Free CF
$49.1M
52W Change
92.3%
Annual Financials
Cash vs Debt
Axcelis Technologies, Inc. holds $366.6M in cash against $70.5M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $49.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 9.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.5% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $920.0M (2022) to $839.0M (2025).
Axcelis Technologies, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Axcelis Technologies, Inc.'s trajectory.